| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d2fdd3b50079b2a618b2785106c24d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bd7a45a343acd10e3f5d8775dda2157 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 |
| filingDate |
2019-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a71d5ab4ee0c668c8022d1db7682c6ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_148e5fe5853c5d0e8c0bc9d9193c8815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a11bdb561fc8f3ae8194102617fb9f88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab4933fe8014eb6203de6680e1821478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a5c2f89644087742618a61287407f3 |
| publicationDate |
2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210089129-A |
| titleOfInvention |
Benzimidazole compounds and their use for treating Alzheimer's disease or Huntington's disease |
| abstract |
The benzimidazole compounds of formula (I) shown below are disclosed. The compound is a potent inhibitor of human glutaminyl cyclase. Also disclosed are pharmaceutical compositions comprising one of such compounds and a pharmaceutically acceptable carrier, as well as methods of treating Alzheimer's disease or Huntington's disease by administering to a subject in need thereof an effective amount of said compound: . |
| priorityDate |
2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |